Endemic typhus caused by Rickettsia (R.) typhi is an emerging febrile disease that can be fatal due to multiple organ pathology. Here Data Availability Statement: All relevant data are within the paper and its supporting information files.
Author summary
Rickettsia typhi causes endemic typhus, a relatively mild disease. However, complications such as encephalitis, hepatitis, pneumonia and others can occur in severe cases. In immunodeficient CB17 SCID mice R. typhi causes a 100% fatal infection and we show here that a1111111111 a1111111111 a1111111111 a1111111111 a1111111111
Introduction
Rickettsioses are emerging febrile diseases that can be fatal and are caused by obligate intracellular bacteria of the family of Rickettsiaceae. This family consists of two genera: Orientia with only one member (Orientia tsutsugamushi) and Rickettsia (R.) that is further subdivided into four groups: The spotted fever group (SFG) that contains the vast majority of rickettsiae (e.g. R. rickettsii, R. conorii), the typhus group (TG; R. prowazekii and R. typhi), the transitional group (R. felis, R. akari and R. australis) and the non-pathogenic ancestral group (R. bellii and R. canadensis) [1, 2] . TG rickettsiae are the causative agents of epidemic typhus (R. prowazekii) and endemic typhus (R. typhi). R. prowazekii is transmitted from human to human by the human body louse while rodents are considered as the dominant natural reservoir for R. typhi and fleas serve as vectors for these bacteria. Rickettsiae primarily infect endothelial cells [3] , leading to local vascular lesions and inflammatory responses that become visible as a characteristic hemorrhagic skin rash in 40-60% of the patients [1] . Symptoms of epidemic and endemic typhus are quite similar. After a 10-14 days period of latency patients suffer from high fever accompanied by headache, muscle and joint pain, nausea and vomiting. Furthermore, neurological symptoms such as confusion and stupor are common [4] . In severe cases, fatal multi-organ pathology including pneumonia, myocarditis, nephritis, hepatitis, splenomegaly and encephalitis/meningitis can occur [4, 5] . The lethality of epidemic typhus is up to 20-30% [5] [6] [7] while the course of disease of endemic typhus is usually milder. The lethality of endemic typhus is estimated to be less than 5% [7, 8] if untreated with antibiotics. Vaccines are not available.
In recent years mouse models of rickettsial infections have been established, using nearly exclusively SFG rickettsiae. While BALB/c and C57BL/6 mice are resistant to the infection with various rickettsiae, C3H/HeN mice were revealed to be susceptible [9] [10] [11] [12] [13] . These mice have been used in various studies to analyze immune response against rickettsiae. CD8 + T cells seem to be critical for protection. C3H/HeN mice depleted of CD8 + T cells died upon infection with a normally sublethal dose of R. conorii while CD4 + T cell-depleted animals showed a similar course of illness as control mice [14] . Furthermore, adoptive transfer of immune CD8 + T cells protected C3H/HeN mice against a lethal challenge with R. conorii [14] but also the transfer of immune CD4 + T cells was protective in this system [14] . The role of CD8 + T cells was further addressed by the infection of CD8 + T cell-deficient C57BL/6 MHCI -/-mice and C57BL/6 Perforin -/-mice that lack the cytotoxic activity of CD8 + T cells and NK cells with R.
australis. Both animals showed enhanced lethality in this infection [15] , demonstrating a critical role of CD8 + T cells and their cytotoxic activity in protection against SFG rickettsiae.
Important cytokines that are involved in rickettsial defense are TNFα and IFNγ. R. conoriiinfected C3H/HeN mice produced enhanced serum levels of IFNγ and IL-12, the main IFNγ-inducing factor for T cells and NK cells [16] , in the first days of infection [12] . Furthermore, depletion of NK cells led to reduced IFNγ release and enhanced susceptibility of C3H/HeN mice to the infection with R. conorii [12] , suggesting the contribution of NK cells to early defense against rickettsiae via the release of IFNγ. Neutralization of either IFNγ or TNFα was associated with reduced nitric oxide (NO) production, led to uncontrolled bacterial growth and was fatal for C3H/HeN mice upon infection with a normally sublethal dose of R. conorii [17] . In line with these observations C57BL/6 IFNγ -/-mice showed enhanced lethality upon R.
australis infection compared to wild-type mice [15] . Knowledge about immune response against TG rickettsiae, however, is still rare. Depletion of NK cells enhanced the susceptibility of normally resistant C57BL/6 mice to R. typhi infection [12] . Depletion of CD8 + T cells as well as the neutralization of IFNγ led to enhanced bacterial growth and mortality of C3H/HeN mice in R. typhi infection [18] . We recently showed that immune CD8 + as well as CD4 + T cells are capable of protecting T and B cell-deficient C57BL/6 RAG1 -/-mice against R. typhi [19] , a model where the bacteria persist for several months and finally cause lethal CNS inflammation [20] . These observations suggest that similar mechanisms including NK cells, T cells, IFNγ and TNFα are involved in protection against both SFG and TG rickettsiae. The current study was performed to further clarify the protective capacity of CD4 + and CD8 + T cells and to decipher the effector mechanisms that are needed for T cell-mediated protection employing BALB/c wild-type mice and the CB17 SCID model of R. typhi infection. In CB17 SCID mice R. typhi induces splenomegaly, severe liver injury and fatal systemic inflammation [21] . Thus, the CB17 SCID model of infection reflects complications that frequently occur in patients with severe outcome of murine typhus [22] . In this model we show that the cytotoxic activity is not essential for CD8 + T cell-mediated protection. 
Methods

Ethics statement
All experimentations and procedures were approved by the Public Health Authorities (Amt fuer Gesundheit und Verbraucherschutz, Hamburg; No 88/13) and performed according to the German AnimalWelfare Act.
Mice
BALB/c, BALB/c IFNγ -/- [23] , BALB/c Perforin -/- [24] and congenic CB17 SCID (CB17/lcrPrkdc SCID /lcrlcoCrl) mice that lack T and B cells due to a genetic autosomal recessive mutation in the Prkdc SCID allele on chromosome 16 [25, 26] were bred and maintained in the animal facilities of the Bernhard Nocht Institute for Tropical Medicine, Hamburg. Animals were housed in a biosafety level 3 facility for experimentation. The facilities are registered by the Public Health Authorities (Amt für Gesundheit und Verbraucherschutz, Hamburg).
Culture, purification and freezing of R. typhi R. typhi (Wilmington strain) was cultivated in L929 mouse fibroblasts (ATCC CCL-1) and purified as described previously [20] . Stocks of purified bacteria were frozen in liquid nitrogen. Spot forming units (sfu) of thawed bacteria were determined by immunofocus assay as described [20] .
Purification of T cells
CD8 + and CD4 + T cells were purified employing the MagniSort Mouse CD4 and CD8 Enrichment kits from eBioscience, Frankfurt, Germany. Procedures were performed according to the manufacturer´s instructions. The purity was generally >95% as determined by flow cytometric stainings.
Infection of mice, adoptive T cell transfer and cytokine neutralization 
Clinical scoring and survival
The health status of the animals was monitored with a clinical score [20] assessing five criteria: posture (0: normal, 1: temporarily curved, 2: curved), fur condition (0: normal, 1: staring in the neck, 2: overall staring), activity (0: normal, 1: reduced, 2: strongly reduced), weight loss (0: < 10%, 1: 10-14%, 2: > 15%) and food and water uptake (0: normal, 1: reduced, 2: none). Mice were euthanized reaching a total score ! 8 or showing weight loss of ! 20%. This point in time was determined as the time of death and used to determine survival rates. The state of health of the animals was assessed by clinical scoring.
Quantitative real-time PCR (qPCR) qPCR was performed as described previously [20] by amplification of a 137 bp fragment of the prsA gene (RT0565) with the forward primer 5´-ACA GCT TCA AAT GGT GGG GT-3´and reverse primer 5´-TGC CAG CCG AAA TCT GTT TTG-3´in a standard SYBR green realtime PCR. A standard template plasmid (pCR2.1-prsA) was used as a reference. Reactions were performed in a Rotor Gene 6000 (Qiagen, Hilden, Germany).
Flow cytometry
Single cell suspensions were prepared from spleen and blood. 
Detection of cytokines in plasma and cell culture supernatants
Bead-based LEGENDplex immunoassay (BioLegend, London, UK) was used for the quantification of plasma cytokines and cytokines in cell culture supernatants. Procedures were performed according to the manufacturer's protocol using cluster tubes (ThermoScientific, Loughborough UK). 12.5 μl of plasma from EDTA blood samples was used diluted 1:2 in assay buffer. Supernatants from bmMF were used non-diluted. Analyses were performed using a BD Accuri C6 (BD Biosciences, San José, USA) and LEGENDplex analysis software (BioLegend, San Diego, USA).
Detection of serum Glutamate Pyruvate Transaminase (GPT)
Serum levels of GPT were evaluated using Reflotron GPT (ALT) stripes and Reflotron Plus device (Roche Diagnostics, Mannheim, Germany) according to the manufacturer's instructions. Serum samples were diluted 1:3 in PBS prior to analyses.
fibroblast medium as a source of M-CSF. Medium was exchanged every 3 days. bmMF were harvested after 12 days and washed twice with PBS prior to use. 
Detection of NO
NO was quantified by Griess reaction in supernatants of bmMF and co-cultures with T cells. Assays were performed in microtiter plates (Greiner Bio-One, Frickenhausen, Germany). 100 μl of sample were mixed with 50 μl Griess 1 reagent (0.5 g sulfonamide in 50 ml 1M HCl) and 50 μl Griess 2 reagent (0.15 g N-(1-Naphtyl)ethylendiamine-dihydrochloride in 50 ml H 2 O). A serial dilution of sodium nitrite (NaNO 2 ) in culture medium was used as a standard (c max 125 μM). The absorbance was measured at 560 nm with a Dynex MRXII spectrophotometric microplate reader (Dynex Technologies, Chantilly, USA).
Statistical analyses
GraphPad Prism 5 software (GraphPad Software, Inc., La Jolla, USA) was used for statistical analysis. The proportion of surviving animals was analyzed with Log-rank (Mantel-Cox) test. For comparison between multiple groups One-way ANOVA (Kruskal Wallis test followed by Dunn´s post test) was used.
Results
BALB/c wild-type mice generate a persistent cytotoxic CD8 + T cell and CD4 + T H 1 response upon R. typhi infection BALB/c mice do not develop symptomatic disease upon R. typhi infection but the bacteria persist [20] . Control of the bacteria in these mice is mediated by the adaptive immune response because T and B cell deficient congenic mice are highly susceptible and succumb to the infection within three weeks [21] . Therefore, we first analyzed the T cell response in BALB/c mice upon R. typhi infection. (Fig 2, middle) .
Approximately 17% of the CD4 + T cells were positive for CD11a in naïve mice (Fig 2, right). CD11a was not expressed at significantly enhanced levels by CD4 + T cells in R. typhiinfected BALB/c mice at any point in time (Fig 2) . Thus, CD4 + T cells in R. typhi-infected ±0.21%) and in the blood of these animals (1.23±0.31%) while CD4 + T cells were absent (spleen: 0.58±0.09%; blood: 0.16±0.06%) ( Fig 3A) . The health status of the animals was monitored by measuring body weight and evaluation by a clinical score. Weight change, clinical score and survival rates of CD4 + and CD8 + recipients and control mice are depicted in Fig 3B. R. typhi-infected CB17 SCID control mice continuously lost weight beginning around day 10 and developed a high clinical score >8 and severe disease until day 20. Mice showing a score !8 were euthanized. This point in time was defined as time of death to analyze survival rates. All CB17 SCID control mice succumbed to the infection before day 21. In contrast, CD8 + T cell recipients neither lost weight nor showed signs of disease at any point in time and all animals survived the infection (Fig 3B) . R. typhiinfected CB17 SCID mice that received CD4 + T cells showed temporary weight loss with similar kinetics as control animals which was significant compared to CD8 + T cell recipients and a low clinical score with a maximum of 4 around day 12 and 13 (p = 0.06 compared to CD8 + T cell recipients) ( Fig 3B) . Surprisingly, except for one animal CD4 + T cell recipient mice recovered until day 20 and survived the infection (Fig 3B) . In addition, GPT levels were detected in the serum during the course of infection as a measure for liver damage that is observed in CB17 SCID mice upon R. typhi infection [21] . In concordance with temporary disease, GPT levels significantly increased in CD4 + T cell recipients until day 14 post infection, reaching comparable levels as in infected control mice. GPT concentrations then declined to background levels again until day 21 when the mice recovered. Serum GPT levels were not increased in CD8 + T cell recipients at any point in time ( Fig 3B) . These data show that both CD8 + as well as CD4 + T cells are capable of protecting CB17 SCID mice from death upon R.
typhi infection although CD4 + T cells are less efficient in protection from R. typhi-induced disease. + T cells in CD8 + recipients) (A). Weight change (n = 5 for control animals and n = 6 for T cell recipient groups), clinical score (n = 5 for control animals and n = 6 for T cell recipient groups), survival (n = 11 for each group) and serum GPT levels (n = 3-5 for each group) were assessed (y-axis) at indicated points in time (x-axis). Differences in the weight change between CD4 + and CD8 + T cell recipients were compared by Mann-Whitney U test at indicated points in time. Statistical analysis of GPT levels was performed by One-way ANOVA (Kruskal Wallis test followed by Dunn´s post) test. Asterisks indicate significant differences compared to day 0 (*p<0.05, **p<0.01). The survival graph shows combined results from 2 independent experiments. Statistical analysis was performed with Log-rank (Mantel-Cox) test. Asterisks indicate significant differences compared to control animals (**p<0.01, ***p<0.001) (B). Serum levels of IFNγ and TNFα and bacterial load in CD4 + and CD8 + T cell recipients
As an indicator for the activation of adoptively transferred T cells we further analyzed serum cytokine levels on day 7 post infection in control mice, CD4 + and CD8 + T cell recipients. Noninfected CB17 SCID mice that received PBS were used as an additional control. At this early point in time in infection, enhanced amounts of IFNγ (248.80±34.54 pg/ml) and TNFα (3.47 ±1.17 pg/ml) were already present in the serum of R. typhi-infected control mice compared to non-infected animals where TNFα was not detectable at all and IFNγ was present at background levels (60.13±30.12 pg/ml). IL- 6 was not yet enhanced in R. typhi-infected CB17 SCID mice (7.48±2.64 pg/ml) compared to non-infected animals (4.90±4.90 pg/ml) and IL-2 was not detectable in these mice as expected. IL-2 was also not measurable in CD8 + T cell recipients.
TNFα (1.94±0.54 pg/ml) was slightly enhanced compared to non-infected animals and comparable to levels measured in infected control animals (3.47±1.17 pg/ml). IFNγ (70.06±23.54 pg/ ml) and IL-6 (2.74±0.79 pg/ml) were detected at background levels in CD8 + T cell recipients, indicating that the immune response is already being terminated. In contrast to CD8 + T cell recipients, IFNγ concentrations were strongly and significantly enhanced in the sera of animals that had received CD4 + T cells (1963±982.30 pg/ml). Similar was also true for TNFα (12.97±5.42 pg/ml) and IL-6 (34.36±14.95 pg/ml) although levels of these cytokines were still quite low. In addition, very low amounts of IL-2 were measurable in the sera from CD4 + T cell recipients (0.63±0.33 pg/ml) ( Fig 4A) . Other T cell-derived cytokines including IL-17A/F and IL-22 were generally not detectable. These data show that adoptively transferred CD4 + T cells produce IFNγ and enhance the inflammatory response at day 7 post infection while the immune response seems to be already terminated in CD8 + T cell recipients at this time.
To analyze the capacity of both CD4 + and CD8 + T cells to eliminate the bacteria in vivo we further determined the bacterial load in different organs of all groups of mice on day 7 post infection by qPCR. Highest numbers of bacteria were generally detectable in the spleen followed by the brain, lung and liver in CB17 SCID mice (Fig 4B and [21] ). At this early point in time after R. typhi infection bacterial numbers were still low. In R. typhi-infected control mice 427.30±263.80 copies were detectable in the spleen, 99.57±46.64 copies in the brain, 6.40±2.14 copies in the lung and 1.43±0.87 copies in the liver. The bacterial load in these organs was unaltered in CD4 + T cell recipients (spleen: 471.20±168.1 copies, brain: 108.40±27.93 copies, lung: 11.10±5.37 copies, liver: 2.09±0.39 copies) at this point in time but significantly reduced in animals that received CD8 + T cells. In fact, the bacteria were already almost absent in the organs of this group of mice (spleen: 11.23±6.26 copies, lung: 0.03±0.01 copies, liver: 0.58±057 copies) except for the brain (33.55±12.41 copies) (Fig 4B) . In control animals, bacterial numbers further increased until death (spleen: 40931±17971 copies, brain: 1151±269.9 copies, lung: 3897±1334 copies, liver 2767±970.4 copies) (Fig 4C) . Five mice of the CD4 + and CD8 + recipient groups were further monitored for 175 days.
One mouse of the CD8 + recipient group died on day 85 for undefined reasons. This animal did not show typical symptoms of R. typhi-induced disease and was not further analyzed. All other animals survived. The bacteria were not detectable in the organs from the CD8 + T cell recipients at this very late point in time (Fig 4B) . Furthermore, the bacteria were also absent in the organs from R. typhi-infected CD4 + recipient mice except for one animal that showed very low numbers of bacteria in the lung (8.65 copies; Fig 4B) . This mouse, however, did not show any signs of disease. These results demonstrate that adoptively transferred CD8 + as well as CD4 + T cells are capable of eliminating R. typhi and provide long-term control of the bacteria.
Role of IFNγ and Perforin for CD4 + and CD8 + T cell-mediated protection of CB17 SCID mice against R. typhi
The results presented so far show that both CD4 + and CD8 + T cells can mediate protection against R. typhi in this model of infection. We next asked which effector functions are required by both cell types to mediate protection and focused on IFNγ as an activator of bacterial killing by macrophages [31, 32] and Perforin which is critical for cell-mediated cytotoxicity [33] [34] [35] . We first infected BALB/c mice lacking either IFNγ or Perforin with R. typhi. Neither BALB/c IFNγ -/-nor BALB/c Perforin -/-mice showed symptoms of disease at any point in time. All From the same mice as described in Fig 3 cytokine levels (yaxis) were determined in plasma on day 7 post infection (n = 7 for each group as indicated on the x-axis). In addition, plasma from non-infected PBS-treated mice (ni; n = 6) was analyzed. Statistical analysis was performed by One-way ANOVA (Kruskal Wallis test followed by Dunn´s post test). Asterisks indicate significant differences (*p<0.05, **p<0.01) (A). Bacterial content (y-axis) in the organs indicated above was quantified by qPCR in each group (R. typhi-infected control mice: open circles, CD4 + T cell recipients: gray circles; CD8 + T cell recipients: black circles) on day 7 (n = 5 for each group) and when the experiment was terminated on day 175 (n = 5 for control mice and CD4 + T cell recipients; n = 4 for CD8 + T cell recipients) post infection (x-axis). Each symbol represents a single mouse. Statistical analysis was performed by One-way ANOVA (Kruskal Wallis test followed by Dunn´s post test). Asterisks indicate significant differences (*p<0.05, **p<0.01) (B). Bacterial content was quantified in R. typhi-infected control animals (n = 5) at the time of death in the indicated organs (xaxis) (C). animals survived the infection for more than 120 days (Fig 5A) , demonstrating long-term protection in the absence of one or the other molecule.
To further elucidate the requirement of IFNγ and Perforin for CD4 + and CD8 + T cell-mediated protection we adoptively transferred either purified CD4 + or CD8 + T cells from BALB/c + IFNγ -/-(black squares), CD8 + Perforin -/-(black circles) and CD4 + IFNγ -/-T cells (gray squares) were adoptively transferred into CB17 SCID mice 1 day prior to the infection with 1×10 6 sfu R. typhi. Control animals were treated with PBS instead receiving T cells (white squares). Weight change (left; n = 5 for each group), clinical score (middle; n = 5 for each group) and survival (right; n = 5 for CD8 + Perforin -/-recipients and n = 10-11 for CD8 + and CD4 + IFNγ -/-recipients) was assessed (y-axis) at indicated points in time (x-axis). The survival graph shows combined results from 2 independent experiments. Statistical analysis was performed with Log-rank (Mantel-Cox) test. Asterisks indicate significant differences compared to control animals (*p<0.05, **p<0.01) (B). All R. typhi-infected CB17 SCID control animals and two mice of the CD4 + T IFNγ -/-cell recipient group died until day 20. At the time of death, the bacterial load (y-axis) was determined in the indicated organs (xaxis) in these animals (C). The bacterial load (y-axis) was also determined in the organs of surviving animals. Organs were taken at indicated points in time from CD8 
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-/-or Perforin -/-mice into CB17 SCID mice. Mice were infected with R. typhi one day after T cell transfer. R. typhi-infected CB17 SCID mice that had received CD4 + IFNγ -/-T cells developed a clinical score and lost body weight between day 9 and 14. However, 70% of these animals recovered and survived the infection (Fig 5B) . R. typhi-infected CB17 SCID mice that had either received CD8 + T cells from IFNγ -/-or Perforin -/-mice never showed any signs of disease and all of the mice survived the infection (Fig 5B) . At the time of death R. typhi-infected control animals had high bacterial loads in all organs (spleen: 38333±7786 copies; liver: 6507±1529 copies; brain: 8781±2093 copies; lung: 5420 ±1620 copies) as observed before while strongly reduced numbers of bacteria were detectable in the organs of the two mice of the CD4 + T cell recipient group that succumbed to the infection (spleen: 277.5±237.6 copies; liver: 1123±416.8 copies; brain: 1632±1243 copies; lung: 561.8 ±414.8 copies) (Fig 5C) . Surviving animals were further followed for more than 120 days and did never show symptoms of disease again. Organs were analyzed for bacterial content when the experiments were terminated (between day 120 and 168 p.i.). Bacterial copy numbers of individual animals are given in table 1 and Fig 5D shows the statistical analysis. R. typhi was not detectable at all in the organs of CD8 + Perforin -/-T cell recipients ( Fig 5D and Table 1 ).
However, low numbers of bacteria were detectable in the majority of the CD8 + IFNγ -/-T cell recipients (5 out of 6 mice). Here, R. typhi was predominantly found in the brain (206.0±192.8 copies) while the lung, liver and spleen were much less affected ( Fig 5D and Table 1 ). In contrast, only 2 out of 8 mice of the CD4 + IFNγ -/-T cell recipients showed low numbers of bacteria in the brain and 1 mouse was positive in the spleen (Fig 5D and Table 1 ). These results demonstrate that CD8 + T cells that either lack cytotoxic function or IFNγ can control the bacteria for a long period of time. For this control, IFNγ seems to be even more critical than the cytotoxic activity. On the other hand, IFNγ-deficient CD4 + T cells are protective (Fig 6A) . The release of IFNγ was strongly but not completely inhibited by the addition of anti-IFNγ (1141±607 pg/ml) and also to some extent upon neutralization of TNFα (6407±3047 pg/ml). Correspondingly, IFNγ release was further inhibited by a combination of anti-IFNγ and anti-TNFα (520.8±270.3 pg/ml) (Fig 6A, left) . TNFα was reduced in the presence of anti-TNFα (24.93±2.68 pg/ml) and a combination of both antibodies (20.70±4.41 pg/ml) but not influenced by the addition of anti-IFNγ (69.56 ±20.93 pg/ml) (Fig 6A, middle) . Although neither the neutralization of IFNγ nor TNFα was complete, the release of IFNγ and TNFα was not significantly enhanced anymore compared to cultures containing naïve T cells. Neutralization of IFNγ further led to the release of the T H 17 cytokine IL-22 by immune CD4 + T cells (176.90±84.08 pg/ml) which was hardly detectable in the absence of anti-IFNγ (10.37±3.65 pg/ml) and comparably increased upon neutralization of both IFNγ and TNFα (162.90±82.76 pg/ml) (Fig 6A, right) . IL-2 was not significantly altered in the presence of the antibodies (Fig 6A, below left) and other cytokines were not detectable. Because T cells are major cellular sources of IFNγ and IL-22 [37, 38] , we conclude that these cytokines are produced by the T cells upon antigen recognition rather than by the macrophages and similar is likely true for TNFα in this system. We further assessed the activation of the bactericidal function of R. typhi-infected macrophages by measuring nitric oxide (NO). Immune CD4 + T cells from wild-type mice induced the release of significant amounts of NO (5.69±1.51 μM) by R. typhi-infected macrophages (Fig 6B) . Although cytokine neutralization was incomplete (Fig 6A) , NO release was comparably and nearly completely abrogated in the presence of either anti-IFNγ (0.40±0.19 μM), anti-TNFα (0.28±0.16 μM) or a combination of both antibodies (0.24±0.15 μM) (Fig 6B) . Moreover, immune but not naïve BALB/c CD4 + T cells strongly inhibited bacterial growth in infected macrophages in vitro (Fig 6C) . Compared to cultures containing naïve CD4 + T cells where 267.6±57.92 R. typhi prsA gene copies were detected, the bacterial content was significantly reduced to 4.86±2.18 copies in the presence of immune CD4 + T cells (Fig 6C) . Bacterial growth was partially restored in the presence of anti-IFNγ (32.35±26.62 prsA copies) and a combination of anti-IFNγ and anti-TNFα (54.05±34.12 prsA copies) while the effect of anti-TNFα alone on bacterial growth was less pronounced (10.73±5.86 prsA copies) (Fig 6C) . Bacterial growth, however, was not completely restored by the addition of neutralizing antibodies and differences were not statistically significant compared to untreated cultures which may be ascribed to incomplete cytokine neutralization (Fig 6A) . To further elucidate a direct influence of IFNγ and TNFα on bacterial growth, additional cultures of R. typhi-infected macrophages were treated with recombinant IFNγ and TNFα in the absence of T cells. Neither IFNγ nor TNFα induced the release of detectable levels of cytokines or NO (Fig 6D) but clearly inhibited bacterial growth. In the absence of recombinant cytokines 1518±367.4 R. typhi prsA gene copies were detectable while only 90.35±40.16 prsA copies and 63.49±31.87 prsA copies were measured in the presence of recombinant TNFα or 6 bone-marrow-derived BALB/c macrophages were infected with 5 copies of R. typhi per cell one day prior to the addition of 2×10 6 purified CD4 + T cells from either naïve or immune BALB/c mice (day 7 post infection). IFNγ and TNFα were neutralized by the addition of 10 μg/ml anti-IFNγ and/or anti-TNFα as indicated on the x-axis. Cytokines were quantified in the supernatants 72h after T cell addition by LEGENDplex assay. IFNγ (left, y-axis), TNFα (middle, y-axis), IL-22 (right, y-axis) and IL-2 (below, left) are shown. Other cytokines were not detectable (A). In addition, NO was detected 72h after T cell addition (B). Bacterial content in the cultures (y-axis) was assessed by prsA-specific qPCR 72h after T cell addition (C). 1×10 6 bone-marrow-derived BALB/c macrophages were treated with recombinant IFNγ (1 U/ml) or TNFα (400 U/ml). NO was quantified in the cell culture supernatants after 72h (D). 1×10 6 bone-marrowderived BALB/c macrophages were infected with 5 copies of R. typhi per cell one day prior to the addition of recombinant IFNγ (1 U/ml) or TNFα (400 U/ml). The cytokines were neutralized by simultaneous addition of either anti-TNFα or anti-IFNγ (10 μg/ml each) as indicated on the x-axis. Bacterial content in the cultures (yaxis) was assessed by prsA-specific qPCR 72h after cytokine addition (E). Graphs show the mean±SEM of combined results from 2 independent experiments (n = 4 T cells from each group of mice (A-C) and n = 2 for the treatment with recombinant cytokines (D-E)). Statistical analysis was performed by One-way ANOVA (Kruskal-Wallis test followed by Dunn´s post test). Asterisks indicate significant differences (*p<0.05, **p<0.01). IFNγ, respectively. This effect was partially abolished upon neutralization of the respective cytokine (TNFα+anti-TNFα: 412.3±42.02 prsA copies, IFNγ+anti-IFNγ: 400.8±73.55 prsA copies). This experiment was performed twice so that statistical analysis was not performed (Fig 6E) . These data demonstrate that both T cell-derived IFNγ and TNFα can contribute to the activation of macrophage bactericidal activity and bacterial killing by CD4 + T cells. (Fig 7B) . The surviving animals of this group lost weight until day 18 and showed a peak clinical score of 3-4 on day 16 post infection. The mice then recovered (Fig 7B) . Surprisingly, the survival rate of anti-TNFα-treated CD4 + IFNγ -/-T cell recipients was higher. 5 out of 7 (86%) of the anti-TNFα-treated CD4 + IFNγ -/-T cell recipients survived the infection (Fig 7B) . Furthermore, disease of these animals was apparently milder and the animals recovered faster. The weight loss of surviving animals of this group was less pronounced and peaked on day 16 post infection (-5.44±2.59%) while isotype-treated surviving CD4 + IFNγ -/-T cell recipients still showed weight loss of -16.45
±1.55% at this point in time (Fig 7B) . In addition, the peak of disease as measured by clinical scoring was 4 days earlier (day 12) than that of isotype-treated CD4 + IFNγ -/-T cell recipients and the animals recovered faster (Fig 7B) . All CD4 + IFNγ -/-T cell recipients that finally succumbed to the infection continuously lost weight and developed a clinical score with similar kinetics or even a little earlier than control mice, whether treated with isotype or anti-TNFα antibody (Fig 7B) . These data show that TNFα obviously exerts pathological effects and is non-beneficial in CD4 + T cell-mediated protection in the absence of IFNγ.
Because CB17 SCID mice develop severe liver necrosis upon R. typhi infection [21] , we also assessed serum GPT levels as a measure for liver damage in all groups of mice at the time of death and in surviving CD4 +
-/-T cell recipients at day 34 post infection when the experiment was terminated. GPT levels in CD4 + IFNγ -/-T cell recipients including those that succumbed to the infection were generally normal, whether treated with isotype antibody or anti-TNFα, while serum GPT was enhanced in control animals compared to non-infected mice (Fig 7C) . Liver damage in control mice was unaltered by the application of anti-TNFα (Fig 7C) . These data show that TNFα is generally not involved in liver damage in R. typhi- + T cells from either naïve or immune BALB/c IFNγ -/-mice (day 7 post infection). TNFα was neutralized by simultaneous addition of 10 μg/ml anti-TNFα. Bacterial content in the cultures (y-axis) was assessed by prsA-specific qPCR 72h after T cell addition. Graphs show the mean and SEM of combined results from two independent experiments (n = 4 T cells from each group of mice) (A). CB17 SCID mice (n = 7 for each group) were infected with 1×10 6 sfu R. typhi. 1×10 6 purified CD4 + T cells from BALB/c IFNγ -/-mice were adoptively transferred one day prior to the infection with R. typhi. Control groups of mice received PBS instead. TNFα was neutralized by intraperitoneal application of 500 μg anti-TNFα every three days beginning on day 3 post infection. Control animals received equal amounts of isotype antibody. The state of health of the mice was monitored by weight change (y-axis, upper left) and a clinical score (y-axis, upper right) and the survival rates (y-axis, below) were assessed. Dotted lines show the data for surviving animals of the isotypeand anti-TNFα-treated groups of CD4 + IFNγ -/-recipients. Statistical analysis of survival rates was performed with Log-rank (Mantel-Cox) test. Asterisks indicate significant differences compared to control animals (**p<0.01) (B). Serum GPT levels (y-axis) were assessed from all groups of animals at the time of death and in surviving animals at the end of the experiment (day 34). Combined results are shown. Each dot represents a single mouse. Statistical analysis was performed by One-way ANOVA (Kruskal Wallis test followed by Dunń s post test) (*p<0.05) (C). The bacterial content (y-axis) in the organs was quantified by prsA-specific qPCR from all animals that succumbed to the infection at the time of death and from surviving animals at the end of the experiment (day 34) as indicated on the x-axis (D). Statistical analysis for C and D was performed by Oneway ANOVA (Kruskal-Wallis test followed by Dunn´s post test). Asterisks indicate statistically significant differences (*p<0.05, **p<0.01). To analyze bacterial clearance, we further quantified the bacterial burden of all animals that succumbed to the infection at the time of death and of surviving mice at day 34 when the experiment was terminated. As expected, control CB17 SCID mice that did not receive T cells developed high and comparable bacterial loads in all organs when treated with isotype antibody (spleen: 94547±30121, brain: 11109±3904, lung: 1624±407.6, liver: 1310±292.6 prsA copies) (Fig 7D) . The application of anti-TNFα did not alter the bacterial load in these animals (spleen: 80536±19501, brain: 12259±2881, lung: 2450±724.8, liver: 828.4±17.1 prsA copies) (Fig 7D) infected macrophages in vitro to achieve antigen-specific restimulation. Naïve CD4 + T cells were used as a control. Cytokines were generally not detectable in cultures containing R. typhiinfected macrophages and naïve CD4 + T cells (Fig 8) . Cultures of infected macrophages and immune wild-type CD4 + T cells produced very high amounts of IFNγ (21749±9799 pg/ml) in addition to IL-2 (1213±104 pg/ml) and lower amounts of TNFα (84.97±23.68 pg/ml). Furthermore, low levels of IL-10 (82.22±31.18 pg/ml) and negligible amounts of IL-22 (10.37±3.65 pg/ml) and IL-6 (10.71±3.09 pg/ml) were measurable in cultures with immune wild-type CD4 + T cells. Other cytokines were not produced (Fig 8) .
In contrast, the supernatants of cocultures of immune CD4 + IFNγ -/-T cells and R. typhiinfected macrophages contained high amounts of IL-17A (3061±1587 pg/ml) and IL-22 (1127 ±401 pg/ml) in addition to low levels of IL-17F (17.76±2.35 pg/ml) while only low amounts of IL-13 (41.13±16.76 pg/ml) were detectable. IL-4 was not produced at all (Fig 8) . Amounts of IL-2 (1407±314 pg/ml), TNFα (56.65±19.59 pg/ml), IL-10 (12.98±6.50 pg/ml) and IL-6 (21.49 ±6.14 pg/ml) were comparable to those produced by cultures with immune wild-type CD4 + T cells (Fig 8) . anti-IL-17A: 11.09±1.15%) (Fig 9A, left) . Second, we analyzed the production of plasma cytokines at the same point in time and included plasma from non-infected CB17 SCID mice as an additional control. In these mice IFNγ was negligible (17.28±7.59 pg/ml) while significantly enhanced amounts of the cytokine were detectable in R. typhi-infected control animals (433.5±97.08 pg/ml). Compared to these, isotype-treated CD4 + IFNγ -/-T cell recipients showed strongly reduced plasma levels of IFNγ (isotype: 53.98±47.90 pg/ml) while amounts of the cytokine were only reduced by half in anti-IL-17A-treated mice (221.4±28.93 pg/ml) (Fig 9A, right) . These data suggest that IL-17A released by the T cells suppresses the production of IFNγ in CB17 SCID mice where NK cells and macrophages represent the major sources of this cytokine upon R. typhi-infection [21] . Enhanced amounts of other cytokines were not detectable at this early point in time. Contrary to our expectations, however, anti-IL-17A-treated CD4 + IFNγ -/-T cell recipients showed much milder disease than isotype-treated animals. All CD4 + IFNγ -/-T cell recipients that received anti-IL-17A hardly lost weight upon R. typhi infection (Fig 9B, left) , showed a very weak temporary clinical score peaking on day 12 post infection ( Fig 9B, middle) and survived the infection (Fig 9B, right) . In contrast, isotype-treated CD4 + IFNγ -/-T cell recipients significantly lost weight between day 14 and 21 compared to anti-IL-17A-treated animals ( Fig  9B, left) . In addition, isotype-treated CD4 + IFNγ -/-T cell recipients developed a significantly higher and prolonged clinical score peaking on day 16 when anti-IL-17A-treated animals already appeared healthy (Fig 9B, middle) . Nonetheless, only one mouse of this group died through the infection (Fig 9B, right) , demonstrating once more that CD4 + T cells are capable of protecting against R. typhi without the capability to produce IFNγ. We further analyzed the bacterial content in the organs of all animals by qPCR. As expected, PBS-treated control mice that died upon infection showed high amounts of bacteria in the spleen (2485±688.9 copies) while the bacterial burden was lower in the brain (677.7 ±255.2 copies), lung (330.3±84.12 copies) and liver (199.7±46.33 copies) (Fig 9C) . In contrast, all CD4 + IFNγ -/-T cell recipients whether treated with isotype antibody or anti-IL-17A were negative for R. typhi in the organs when the experiment was terminated on day 26 post infection. Furthermore, also the only mouse of the isotype-treated CD4 + IFNγ -/-T cell recipient -/-mice were adoptively transferred into CB17 SCID mice one day prior to the infection with 1×10 6 sfu R. typhi. IL-17A was neutralized by intraperitoneal application of 500 μg anti-IL-17A every two days beginning on day 2 post infection (n = 10). A second group of T cell recipients received isotype antibody (n = 10). R. typhi-infected control mice did not receive T cells and were treated with PBS instead of antibody (n = 5). The CD4 + T cell frequency among leukocytes in the blood (y-axis) was determined on day 8 post transfer (left). CD8 + T cells were not detectable. Plasma cytokines were detected by LEGENDplex assay. Plasma from naïve CB17 SCID mice (n = 10) was used as a control. Only IFNγ (y-axis) was detectable at significant amounts. Statistical analysis was performed by One-way ANOVA (Kruskal Wallis test followed by Dunn´s post test) (*p<0.05, ***p<0.001) (A). The state of health of the mice was monitored by weight change (y-axis, left) and a clinical score (y-axis, middle) and the survival rates (y-axis, right) were assessed. Statistical analysis of survival rates was performed with Log-rank (Mantel-Cox) test. Differences in the survival of anti-IL-17A-and isotype-treated animals were not significant (B). The bacterial content (y-axis) in the organs was quantified by prsA-specific qPCR from all control animals that succumbed to the infection at the time of death and from all CD4 + IFNγ -/-T cell recipients including the mouse of the isotype-treated group that died on day 16 post infection. Samples from the surviving animals were taken at the end of the experiment (day 26). Statistical analysis was performed by One-way ANOVA (Kruskal-Wallis test followed by Dunn´s post test). Asterisks indicate statistically significant differences (**p<0.01, ***p<0.001) (C). group that died upon infection on day 16 had only very low amounts of bacteria predominantly in the liver (52.0 copies) followed by the brain (20.8 copies), lung (6.49 copies) and spleen (1.01 copies) (Fig 9C) .
These data demonstrate that IL-17A exerts pathological effects similar to TNFα, and that this cytokine is also not essential for bacterial elimination by CD4 + IFNγ -/-T cells in vivo.
Discussion
In the current study we describe the T cell response in R. typhi-infected BALB/c mice and show by adoptive transfer into congenic CB17 SCID mice, a lethal model of R. typhi infection [21] [40] . Surprisingly, in BALB/c mice activated T cells were again detectable late in infection at day 35. This observation is interesting as we could recently show that R. typhi persists in BALB/c as well as in C57BL/ 6 wild-type mice [20] . Reactivation of T cells, however, was not observed in R. typhi-infected C57BL/6 mice that instead seem to maintain a certain level of effector cells until day 35 [19] .
Comparing the T cell response of BALB/c and C57BL/6 mice it is obvious that both the activation of cytotoxic CD8 + T effector cells and IFNγ-expressing CD4 + T cells both of which are important for the control of intracellular pathogens is less efficient in animals of the BALB/c background upon R. typhi infection. For example, 5% of the CD8 + T cells expressed Granzyme B in R. typhi-infected BALB/c mice at the peak of response on day 7 while 10% of the CD8 + T cells
were Granzyme B + in C57BL/6 mice at this point in time [19] . Similar was true for the CD4 + T cell effector response. Approximately 8% of the CD4 + T cells in BALB/c mice expressed IFNγ on day 7 whereas 14% of the CD4 + T cells were IFNγ + in C57BL/6 mice [19] . Less efficient induction of T H 1 and cytotoxic T cells in BALB/c mice compared to C57BL/6 mice has been also described for other infections such as Leishmania major [41] . The weaker T cell response could be the reason why sporadic reactivation of T cells is necessary to control persisting R. typhi in BALB/c mice while the continuous presence of low numbers of activated T cells is sufficient to control the bacteria in C57BL/6 mice. Adoptively transferred CD8 + T cells efficiently and quickly eliminated the bacteria in R.
typhi-infected CB17 SCID mice. The bacteria were almost completely eradicated in the organs already by day 7 post infection in CD8 + T cell recipients. Furthermore, these animals were completely protected from R. TG rickettsiae but may be even more important than the cytotoxic activity, at least for longterm control of the bacteria. IFNγ activates the bactericidal activity of macrophages and endothelial cells by inducing the expression of iNOS and subsequent release of NO [31, 32, 42] . Both endothelial cells and macrophages are target cells of rickettsiae [1, 43, 44] Both IFNγ and TNFα have been shown to be important in defense against a number of intracellular pathogens. TNFα enhances the phagocytic activity and helps macrophages to control intracellular growth of Mycobacterium (M.) tuberculosis [54] . IFNγ further induces the expression of TNFα in macrophages which is required for IFNγ-mediated induction of iNOS [55] , and coactivation by IFNγ and TNFα is needed for the induction of full bactericidal activity and granuloma formation in M. tuberculosis infection [56] . Similarly, IFNγ and TNFα were found to be important in rickettsial defense. Neutralization of either IFNγ or TNFα leads to enhanced bacterial growth and fatality in R. conorii-infected C3H/HeN mice [17] . Second, C57BL/6 IFNγ -/-mice show enhanced susceptibility and lethality in the infection with R. australis [15] . It has been assumed that TNFα produced by macrophages acts in a synergistic manner with T cell-and NK cell-derived IFNγ on adjacent infected cells such as endothelial cells, hepatocytes and macrophages to induce NO production and rickettsial killing [17] . Indeed, we found that macrophages express TNFα in R. typhi-infected CB17 SCID mice. In addition, NK cells as well as macrophages produce IFNγ in these animals upon R. typhi infection [21] . Nonetheless, the high amounts of IFNγ and TNFα that are released by NK cells and macrophages in CB17 SCID mice upon R. typhi infection are not protective but rather seem to be the reason for death [21] . Together with the findings from the current study these observations suggest that IFNγ and TNFα must be locally provided by T cells to act bactericidal, and that both cytokines are involved in protection mediated by IFNγ-competent CD4 + T cells.
Because IFNγ is considered the most important cytokine involved in protection against intracellular pathogens including rickettsiae, it was then surprising that this cytokine is obviously not essential for protection against R. typhi. [58] [59] [60] . In recent years, however, T H 17 cells have also been implicated in defense against intracellular bacteria and parasites. IL-17A and F mediate in part similar biological effects [61, 62] and induce the activation of NF-κB [63] [64] [65] and the production of granulopoietic factors such as G-CSF, GM-CSF and stem cell factor and chemokines (CXCL-1, CXCL-2, CXCL-5, CXCL-8) that are involved in the recruitment of neutrophils [57] . These can contribute to parasite elimination. Apart from that, IL-17A/F induce the release of inflammatory cytokines (TNFα, IL-6, IL-1β) and matrix metalloproteases (MMPs) in tissue cells and macrophages [66] [67] [68] [69] [70] and of antimicrobial peptides in tissue cells in concert with IL-22 [71, 72] . In addition, both IL-17A and IL-22 exert direct antiparasitic effects in target cells. IL-17A reduces the growth of the intracellular bacterium Chlamydia (C.) muridarum in the lung of infected mice in vivo and in lung epithelial cells and macrophages in vitro in an iNOS-dependent manner [73] . IL-17A promotes IFNγ-induced expression of iNOS and NO release in lung epithelial cells in vivo and acts protective in the infection with C. muridarum [73] . In line with these findings, IL-17A was found to promote the expression of iNOS and the release of NO by macrophages infected with Mycobacterium bovis bacillus Calmette-Guerin (BCG) [74] . In addition, IL-17A directly inhibits the growth of the intracellular parasite Trypanosoma (T.) cruzi in infected macrophages in vitro [75] . Here, killing of intracellular T. cruzi parasites is mediated via the activation of the NAPDH oxidase [75] that produces superoxide and other reactive oxygen species (ROS) that can mediate killing of intracellular pathogens in macrophages and neutrophils similar to NO [76] . A protective activity of T H 17 cells was further demonstrated in the infection with T. cruzi in vivo. Adoptive transfer of T. cruzi-specific TCR-transgenic T H 17 cells into C57BL/6 RAG1 -/-mice protects the animals against a lethal challenge with T. cruzi [75] . Finally, treatment of epithelial cells infected with the intracellular apicomplexan parasite Eimeria (E.) falciformis with either IFNγ, IL-22 or IL-17A reduces parasite growth in vitro [77] . Moreover, C57BL/6 IFNγR -/-as well as C57BL/6
IFNγ -/-mice infected with this parasite showed higher pathology and body weight loss but reduced pathogen burden compared to wild-type mice [77] , demonstrating that IFNγ is dispensable for the elimination of this pathogen. As observed for CD4 + T cells in the infection of BALB/c IFNγ -/-mice with R. typhi, the infection of C57BL/6 IFNγ -/-mice with E. falciformis was also associated with increased production of IL-17A and IL-22 by CD4 + T cells, and the authors further show that the neutralization of both IL-22 and IL-17A or IL-22 alone in C57BL/6 IFNγR -/-mice leads to increased parasite load in vivo [77] , indicating a dominant protective effect of IL-22 in this infection. Surprisingly, the neutralization of IL-17A in R. typhi-infected CD4 + IFNγ -/-recipient mice led to a very similar outcome as the neutralization of TNFα (milder disease, reduced body weight loss and increased probability to survive the infection), and the animals were still capable of eliminating the bacteria. These findings demonstrate pathological effects of IL-17A. In this context, it is interesting that the neutralization of both IL-17A and IL-22 but not one or the other cytokine alone in E. falciformis-infected C57BL/6 IFNγR -/-mice abolished body weight loss [77] . This indicates pathological effects of IL-17A as well as of IL-22 that have been also implicated in other situations such as progressive airway inflammation in a murine model of bleomycin-induced airway inflammation [78] . As mentioned before, IL-17A induces the release of inflammatory cytokines such as IL-6, TNFα and IL-1β [66] [67] [68] [69] [70] . IL-17A may further synergize with these mediators to aggravate tissue inflammation and damage [79, 80] 
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